Britt Bickert, PA
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 134 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 28 manufacturers reported payments, led by Saluda Medical Americas, Inc. at 34.4% of the total. Reporting peaked in 2021 at $1,218 and has fallen 85.0% since, to $183 in 2025.
Across 134 payments — averaging $25.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Saluda Medical Americas, Inc.$1K
- Nevro Corp.$508
- AbbVie$400
- Relievant Medsystems, Inc.$266
- Merz Pharmaceuticals, LLC$110
- Medtronic$94
- plus $857 from 22 others
What the payments were for
- Food & beverage$3,405100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Saluda Medical Americas, Inc. | 30 | $1,170 |
| Nevro Corp. | 26 | $508 |
| AbbVie(2 entities) | 21 | $400 |
| Relievant Medsystems, Inc. | 5 | $266 |
| Merz Pharmaceuticals, LLC | 3 | $110 |
| Medtronic | 5 | $94 |
| Biodelivery Sciences International, Inc. | 5 | $86 |
| Boston Scientific | 3 | $74 |
| Biohaven Pharmaceuticals, Inc. | 4 | $67 |
| Pfizer | 3 | $66 |
| Amgen(2 entities) | 3 | $59 |
| Kowa Pharmaceuticals America, Inc. | 3 | $57 |
| Tersera Therapeutics LLC | 3 | $55 |
| Collegium Pharmaceutical, Inc. | 3 | $55 |
| Teva Pharmaceuticals USA, Inc. | 2 | $43 |
| Arbor Pharmaceuticals, Inc. | 2 | $37 |
| Sanofi-aventis U.S. LLC | 1 | $36 |
| Vanda Pharmaceuticals Inc. | 1 | $31 |
| Lilly USA, LLC | 2 | $26 |
| Piramal Critical Care | 1 | $23 |
| Baudax Bio Inc. | 1 | $22 |
| Novartis | 1 | $22 |
| GRT US Holding, Inc. | 1 | $21 |
| Si-bone, Inc. | 1 | $21 |
| Idorsia Pharmaceuticals US Inc | 1 | $16 |
| Johnson & Johnson | 1 | $15 |
| Forte Bio-pharma LLC | 1 | $14 |
| Nalu Medical, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,405 in reported general payments places this provider in the 75th percentile of 250 medical providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 22 | $408 |
| Cefdinir | 20 | $244 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 17 | $128 |
| Cephalexin | 16 | $92 |
| Azithromycin | 18 | $79 |
| Diclofenac Sodium | 16 | $69 |
| Prednisone | 14 | $22 |
Paid to pharmacies, not to this prescriber.
Other medical in Reno
- Ashley OwensReno$7K
- Christine BurnsReno$7K
- Brian DouglasReno$7K
- Sarah GutierrezReno$6K
- Bradley BusReno$6K
- Melissa ShelleyReno$6K
- Gretchen GoicoecheaReno$5K
- Nicholas BeaudetteReno$4K
- Shaylee NystromReno$4K
- Sheila QuinnReno$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.